BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cairns EA, Toguri JT, Porter RF, Szczesniak AM, Kelly ME. Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular disease. J Basic Clin Physiol Pharmacol 2016;27:253-65. [PMID: 26565550 DOI: 10.1515/jbcpp-2015-0065] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Zhou J, Kamali K, Lafreniere JD, Lehmann C. Real-Time Imaging of Immune Modulation by Cannabinoids Using Intravital Fluorescence Microscopy. Cannabis Cannabinoid Res 2021;6:221-32. [PMID: 34042507 DOI: 10.1089/can.2020.0179] [Reference Citation Analysis]
2 Miller S, Leishman E, Hu SS, Elghouche A, Daily L, Murataeva N, Bradshaw H, Straiker A. Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model. Invest Ophthalmol Vis Sci 2016;57:3287-96. [PMID: 27333182 DOI: 10.1167/iovs.16-19356] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
3 Miller S, Kulkarni S, Ciesielski A, Nikas SP, Mackie K, Makriyannis A, Straiker A. Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure. Pharmaceuticals (Basel) 2018;11:E50. [PMID: 29786643 DOI: 10.3390/ph11020050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
4 Cruz SL, Sánchez-Miranda E, Castillo-Arellano JI, Cervantes-Villagrana RD, Ibarra-Sánchez A, González-Espinosa C. Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB2 and GPR55 receptor activation. Possible involvement of CB2-GPR55 heteromers. Int Immunopharmacol 2018;64:298-307. [PMID: 30243065 DOI: 10.1016/j.intimp.2018.09.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
5 Lafreniere JD, Kelly MEM. Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options. Neuronal Signal 2018;2:NS20170144. [PMID: 32714590 DOI: 10.1042/NS20170144] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Toguri JT, Caldwell M, Kelly ME. Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain. Front Pharmacol 2016;7:304. [PMID: 27695415 DOI: 10.3389/fphar.2016.00304] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
7 Papadogkonaki S, Theodorakis Κ, Thermos K. Endogenous and synthetic cannabinoids induce the downregulation of cannabinoid CB1 receptor in retina. Experimental Eye Research 2019;185:107694. [DOI: 10.1016/j.exer.2019.107694] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
8 Porter RF, Szczesniak AM, Toguri JT, Gebremeskel S, Johnston B, Lehmann C, Fingerle J, Rothenhäusler B, Perret C, Rogers-Evans M, Kimbara A, Nettekoven M, Guba W, Grether U, Ullmer C, Kelly MEM. Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis. Molecules 2019;24:E3338. [PMID: 31540271 DOI: 10.3390/molecules24183338] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Murataeva N, Miller S, Dhopeshwarkar A, Leishman E, Daily L, Taylor X, Morton B, Lashmet M, Bradshaw H, Hillard CJ, Romero J, Straiker A. Cannabinoid CB2R receptors are upregulated with corneal injury and regulate the course of corneal wound healing. Exp Eye Res 2019;182:74-84. [PMID: 30905716 DOI: 10.1016/j.exer.2019.03.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
10 Ahmed I, Rehman SU, Shahmohamadnejad S, Zia MA, Ahmad M, Saeed MM, Akram Z, Iqbal HMN, Liu Q. Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders. Molecules 2021;26:3389. [PMID: 34205169 DOI: 10.3390/molecules26113389] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Di Zazzo A, Yang W, Coassin M, Micera A, Antonini M, Piccinni F, De Piano M, Kohler I, Harms AC, Hankemeier T, Boinini S, Mashaghi A. Signaling lipids as diagnostic biomarkers for ocular surface cicatrizing conjunctivitis. J Mol Med (Berl) 2020;98:751-60. [PMID: 32313985 DOI: 10.1007/s00109-020-01907-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Aiello F, Gallo Afflitto G, Li JO, Martucci A, Cesareo M, Nucci C. CannabinEYEds: The Endocannabinoid System as a Regulator of the Ocular Surface Nociception, Inflammatory Response, Neovascularization and Wound Healing. J Clin Med 2020;9:E4036. [PMID: 33327429 DOI: 10.3390/jcm9124036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Kelly MEM, Lehmann C, Zhou J. The Endocannabinoid System in Local and Systemic Inflammation. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2017;9:i-192. [DOI: 10.4199/c00151ed1v01y201702isp074] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Cairns EA, Szczesniak AM, Straiker AJ, Kulkarni PM, Pertwee RG, Thakur GA, Baldridge WH, Kelly MEM. The In Vivo Effects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice. J Ocul Pharmacol Ther 2017;33:582-90. [PMID: 28719234 DOI: 10.1089/jop.2017.0037] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
15 Bouskila J, Bleau M, Micaelo-Fernandes C, Bouchard JF, Ptito M. The Inhibition of the Degrading Enzyme Fatty Acid Amide Hydrolase Alters the Activity of the Cone System in the Vervet Monkey Retina. Brain Sci 2021;11:1418. [PMID: 34827417 DOI: 10.3390/brainsci11111418] [Reference Citation Analysis]
16 Garai S, Kulkarni PM, Schaffer PC, Leo LM, Brandt AL, Zagzoog A, Black T, Lin X, Hurst DP, Janero DR, Abood ME, Zimmowitch A, Straiker A, Pertwee RG, Kelly M, Szczesniak AM, Denovan-Wright EM, Mackie K, Hohmann AG, Reggio PH, Laprairie RB, Thakur GA. Application of Fluorine- and Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of Cannabinoid 1 Receptor Positive Allosteric Modulators. J Med Chem 2020;63:542-68. [PMID: 31756109 DOI: 10.1021/acs.jmedchem.9b01142] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]